Business
JM Financial Predicts Up To 28 Percent Growth For Two Major Drug Companies
Reported by Rohit Yadav (Staff Writer) · Economic Times - Markets ·
✓ — also reported by Livemint - Markets
Representative image · PexelsJM Financial kept its buy ratings on Dr Reddy's Laboratories and Aurobindo Pharma after predicting a possible price rise of up to 28 percent over the next 12 months. The financial firm stated that better earnings growth, wider business setups, and new product releases will help both drug companies move forward in the market.
More in Business
Representative image · Wikimedia CommonsBusiness
PL Capital upgrades AAVAS Financiers to buy, sees 33% upside
Reported by Ishita Mukherjee (Staff Writer) · Livemint - Markets · ✓
Representative image · PexelsBusiness
China loan growth slows to new normal, says PBOC chief
Reported by Faizan Khan (Staff Writer) · Economic Times - Markets ·
Representative image · Wikimedia CommonsBusiness
Rentomojo IPO to open at ₹511 on Sept 17, sees 73‑times demand
Reported by Abhishek Tiwari (Copy Editor) · Livemint - Markets ·